UnitedHealth raised its 2026 adjusted earnings outlook, beat second-quarter estimates and doubled its share-buyback target, sending the stock to its highest level in more than a year. CEO Stephen Hemsley told investors the insurer was returning to form as performance disciplines took hold.
UnitedHealth Group lifted its 2026 adjusted earnings-per-share outlook to $19.50-$20, well above the $18.48 consensus and its previous forecast of more than $18.25. The upgrade landed alongside a major second-quarter profit beat and a doubled buyback. UNH shares rose 1% on Thursday to close at $423.38, then added another 1% in extended trading.
Q2 beat resets the numbers
The insurer reported adjusted earnings of $6.38 per share, well above the $4.92 consensus and up from $4.08 a year earlier. Revenue reached $112.03 billion, topping Wall Street's $110.86 billion estimate and holding broadly flat year-over-year. The medical care ratio improved to 86.7% from 89.4%, helped by $860 million of favorable prior-period medical development.
Management also raised its segment targets, lifting UnitedHealthcare's operating-profit outlook to at least $12 billion and Optum Health's forecast to at least $2.2 billion.
A bigger buyback signals confidence
UnitedHealth raised its 2026 share-repurchase target to at least $5 billion from $2.5 billion. It had already spent $4 billion buying back 11.4 million shares through mid-July. CFO Wayne DeVeydt called the earnings quite durable and described the new outlook as the right stepping off point for future growth.
Hemsley reinforced that message, reaffirming the company's long-term goal of 13% to 16% annual earnings growth. On the quality of those earnings, he said: "I think the quality of earnings is exceptional."
Medicare Advantage carries the quarter
Stronger Medicare Advantage results drove the quarter, with medical costs coming in below the company's assumptions. UnitedHealth still expects Medicare Advantage enrollment to fall by about 1.1 million this year, yet it forecasts margins above 3%. Commercial plans remain under pressure, however, with medical-cost trends running modestly above 11%.
The company is also leaning on AI to cut administrative work, saying the tools helped add nearly 200,000 patient-facing hours and cut clinician cognitive burnout by 90%. Retail market sentiment shifted too. On Stocktwits, readings jumped to 'extremely bullish' from 'bullish' a day earlier amid nearly a 500% surge in 24-hour message volume.
Source: TradingView
Trading involves risk.
Risk Disclaimer
